BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1974342)

  • 1. Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina.
    Berchuck A; Rodriguez G; Kamel A; Soper JT; Clarke-Pearson DL; Bast RC
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):381-7. PubMed ID: 1974342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium.
    Bigsby RM; Li AX; Bomalaski J; Stehman FB; Look KY; Sutton GP
    Obstet Gynecol; 1992 Jan; 79(1):95-100. PubMed ID: 1345772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study.
    Wu X; Xin Y; Yao J; Hasui K; Tsuyama S; Yonezawa S; Murata F
    Med Electron Microsc; 2001 Sep; 34(3):179-84. PubMed ID: 11793194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma.
    Lee EY; Cibull ML; Strodel WE; Haley JV
    Arch Pathol Lab Med; 1994 Mar; 118(3):235-9. PubMed ID: 7907854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the HER-2/neu oncogene in gynecologic cancers.
    Cirisano FD; Karlan BY
    J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of the vagina.
    Wilkinson EJ
    Curr Opin Obstet Gynecol; 1991 Aug; 3(4):553-60. PubMed ID: 1678972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of proliferating-cell nuclear antigen and epidermal growth factor receptor in intraepithelial squamous cell lesions of human bronchus.
    Yoneda K
    Mod Pathol; 1994 May; 7(4):480-6. PubMed ID: 7915034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.
    Press MF; Hung G; Godolphin W; Slamon DJ
    Cancer Res; 1994 May; 54(10):2771-7. PubMed ID: 7909495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu expression in Paget disease of the vulva and the female breast.
    Brummer O; Stegner HE; Böhmer G; Kühnle H; Petry KU
    Gynecol Oncol; 2004 Nov; 95(2):336-40. PubMed ID: 15491754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Fanconi's anemia and squamous-cell carcinoma of the lower female genital tract with condyloma acuminatum. A report of two cases.
    Wilkinson EJ; Morgan LS; Friedrich EG
    J Reprod Med; 1984 Jul; 29(7):447-53. PubMed ID: 6481701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
    Chang JL; Tsao YP; Liu DW; Han CP; Lee WH; Chen SL
    Gynecol Oncol; 1999 Apr; 73(1):62-71. PubMed ID: 10094882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
    Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
    Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
    Bacus SS; Gudkov AV; Zelnick CR; Chin D; Stern R; Stancovski I; Peles E; Ben-Baruch N; Farbstein H; Lupu R
    Cancer Res; 1993 Nov; 53(21):5251-61. PubMed ID: 8106145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
    Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.
    Pietras RJ; Fendly BM; Chazin VR; Pegram MD; Howell SB; Slamon DJ
    Oncogene; 1994 Jul; 9(7):1829-38. PubMed ID: 7911565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
    Khan AJ; King BL; Smith BD; Smith GL; DiGiovanna MP; Carter D; Haffty BG
    Clin Cancer Res; 2002 Feb; 8(2):540-8. PubMed ID: 11839675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.